Join us at ISOQOL’s annual conference

ISOQOL’s annual conference will be a key milestone for us at Modus this year. Not only because 5 years ago the idea of Modus Outcomes came about after a meeting in Dublin and a Guinness or two, but also because we will be presenting our research! On Wednesday afternoon (October 24), Antoine will co-lead a workshop on a […]

Modus Outcomes pushing the boundaries of measurement in health

This month saw the XXII World Congress of the International Measurement Confederation (IMEKO), a voluntary, non-governmental federation of 42 metrological organizations from all over the world. The conference was held in Belfast, UK and hosted by the Institute of Measurement and Control with support from the National Physical Laboratory. Its theme was ‘Knowledge Through Measurement’. Excitingly for the […]

Another busy week for Modus Outcomes!

On April 9th, in downtown New York City, we hosted our third ‘Patient-centered drug development: reflections, challenges & solutions’ workshop entitled: ‘Why we need to move to modern test theory: real world examples’. Once again, our roundtable event gathered a strong group of industry, academic and clinical representatives. Our external invited speakers included Professor Peter […]

Patient-Centered Drug Development: Reflections, Challenges, & Solutions: The Success Story Continues

Following the success of our inaugural event in May 2017, and an overwhelming demand to host a second roundtable workshop, we were pleased to host our second invitation-only event “Patient-Centered Drug Development: Reflections, Challenges, & Solutions” on November 8th, 2017 at the Glasgow Science Center, Glasgow, Scotland. During this exclusive event we brought together strategic […]

Patient-centered outcomes in rare diseases: breakthrough paper co-authored by Thomas Morel (KU Leuven) and Stefan Cano (Modus Outcomes):

Learn in this article how a concept-driven measurement approach addresses the many challenges of evaluating direct treatment benefit in rare diseases. Modus Outcomes’ team has developed successful concept-driven measurement solutions for sponsors in rare diseases. More specifically, we can help you: Run a tailored workshop on the lessons from the paper Apply these solutions to […]

When FDA met Q-PORTFOLIO: why the rave reviews are relevant to Modus Outcomes

Last week, Modus Outcomes’ own Stefan Cano (, together with Professors Anne Klassen (McMaster University; and Andrea Pusic (Memorial Sloan Kettering Cancer Center;, visited the Center for Devices and Radiological Health (CDRH) at the US Food and Drug Administration. This is the third time the trio has been invited by FDA to present […]